MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF...
-
Upload
gordon-mccormick -
Category
Documents
-
view
218 -
download
1
Transcript of MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF...
![Page 1: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/1.jpg)
1
MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY
WHAT WORKS?SHELLEY ASKEW FLOYD, MS
DIRECTOR OF PHARMACOTHERAPY SERVICESPYRAMID HEALTHCARE, INC.
![Page 2: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/2.jpg)
2
OBJECTIVES:
1. Understanding the importance of medication assistance treatment(MAT) in a LICENSED, CERTIFIED opioid treatment program as a viable strategy to overdose prevention
2. Provide current listing of opioid treatment options available
3. Present challenges and benefits of each
![Page 3: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/3.jpg)
3
Pharmacotherapy~
The combined use of medication and psychotherapy in a treatment facility.
Why is this important?- medication complements psychosocial supports/therapy by quieting the brain so counseling can work without the need of the dependent drug…
![Page 4: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/4.jpg)
4
Who regulates methadone treatment facilities:
Substance Abuse and Mental Health Services Administration (SAMHSA)
Drug Enforcement Agency
Department of Drug & Alcohol Programs-PA Chapter 715
Accreditation Entities (i.e.CARF, JCAHO)
![Page 5: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/5.jpg)
5
History of MAT
Late 19th- Early 20th Century
Public perceptions was that Addiction WAS NOT A DISEASE
Saw increased use in 1950’s and 1960’s (morphine/heroin)
Early 1970’s Addiction IS A DISEASE
Methadone treatment in OTP begins
![Page 7: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/7.jpg)
7
Effective medication assisted treatment has the following desired outcomes:
~Prevention of the onset of subjective/objective signs of opioid abstinence syndrome for at least 24 hours (post acute withdrawal)
~Reduction or elimination of drug craving routinely experienced by the patient
~Blockage of the euphoric effects of any illicitly acquired self administered drug without the patient experiencing or observers noticing undesirable effects
![Page 8: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/8.jpg)
8
WHAT ARE THE CHOICES?
Traditional agonist therapy medications
Methadone & Buprenorphine
AND
Naltrexone
Antagonist therapy medication
![Page 9: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/9.jpg)
9
WHAT IS THE DIFFERENCE?
![Page 10: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/10.jpg)
10
Agonist-a chemical that binds to a receptor and activates the receptor in the same way as opioid drugs.
Partial Agonist-activate receptors by stimulating the dopamine reward pathway.
Antagonist-binds to opioid receptors but rather than producing an effect, they block the effects of opioids.
![Page 11: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/11.jpg)
11
Methadone (Full opioid agonist)-never formally approved by the FDA but most commonly used for treatment
Buprenorphine (Partial agonist)- Two formulas containing buprenorphine were approved by the FDA for use in the US in Oct 2000. Subutex® (buprenorphine only) and buprenorphine w/naloxone (Suboxone®). Both can be prescribed in a certified physician’s office and now in a LICENSED, CERTIFIED ClINIC
Naltrexone(Antagonist)- Revia® approved in 1984. Vivitrol® was first approved by the FDA for the treatment of alcohol dependence 2006. It received subsequent approval by the FDA for the use of opioid treatment in Oct 2010.
![Page 13: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/13.jpg)
13
The first couple of weeks after opioid detox is the most vulnerable period for relapse and overdose.
No 1 shop fits all in the treatment of opioid dependence. The intervention must fit individual need based on:
-Symptoms -Length of dependence
-Medical History & complexities -Setting/location of the program -Individual ability & desire to change
![Page 14: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/14.jpg)
14
GUIDELINES FOR CONSIDERATION
![Page 15: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/15.jpg)
15
Consider Methadone first when:
History of addiction is severe to moderate > 18-24 months ~Current physiologically dependence and at least one year prior physiologically dependent
~2 documented attempts at short term treatment within 12 months prior to seeking admission
~Pregnant (physiologic dependency requirement waived)-current standard of care
~Inadequate psychosocial or recovery supports, e.g. safe and stable housing, supportive family, employed/in school, etc.
![Page 16: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/16.jpg)
16
Methadone Continued:
~Recent documented overdose
~Recently released from prison/jail environment with history of MAT treatment prior to incarceration
~Not successful in adhering to Buprenorphine treatment program requirements
~Age 18 years and above
![Page 17: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/17.jpg)
17
Methadone continued:
Benefits:~Used for the treatment of pain~Highly regulated in OTP’s~Daily monitoring with gradual “freedom” (take homes)
Drawbacks:~Narcotic~Can be addictive physiologically and/or physically~Precipitated withdrawal if discontinued abruptly~Drug interactions
![Page 18: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/18.jpg)
18
Consider Buprenorphine first
History of addiction moderate to mild > 12-18 months ~Unable to access a methadone treatment clinic or difficulty adhering to scheduled hours for dosing
~Documented severe, uncontrollable adverse effect or true hypersensitivity to methadone
~Not dependent or abusing Central Nervous System (CNS) depressants, including benzodiazepines and alcohol
![Page 19: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/19.jpg)
19
Buprenorphine continued:
~Does not have a history of multiple treatment attempts and relapses, except those with multiple detox attempts and relapses
~Mental health disorder, if present, is stable, e.g.” no emotional, behavioral or cognitive conditions that would complicate treatment
~
![Page 20: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/20.jpg)
20
Buprenorphine continued:
~No prior adverse reactions to buprenorphine or naloxone or taking medications that might adversely interact
~Pregnant women may be good candidates (not label indicated)
~Age 16 years and above
![Page 21: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/21.jpg)
21
Buprenorphine continued:
Benefits: -More conducive to an engaged lifestyle -Most insurances cover medication and counseling-Counseling requirements Drawbacks:-Diversion issues-Multiple doses-Minimum oversight-Counseling requirements-Payer requirements
![Page 22: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/22.jpg)
22
Consider Vivitrol® when:
History of addiction mild or special populations < 12-18 months ~Not interested in methadone or buprenorphine
~Abstinent from opioids 7-10 days prior
~Recovery environment/psychosocial circumstances sufficiently supportive and stable
~Mental health disorder, if present, is stable, e.g.” no emotional, behavioral or cognitive conditions that would complicate treatment
![Page 23: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/23.jpg)
23
Vivitrol® continued:
~Exclude acute hepatitis or liver failure
~Not dependent on or abusing Central Nervous System (CNS) depressants, including benzodiazepines and alcohol
~Easier to use in residential settings after detox from opioid
Benefits:~Monthly injection~Non-addictive~Not a narcotic~Will not precipitate withdrawal when discontinued
![Page 24: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/24.jpg)
24
Vivitrol® continued:
Draw backs:~Strongest effects are in the first three weeks~Must be opioid free for 7-10 days~Individuals transitioning from buprenorphine or methadone may be vulnerable to precipitated withdrawal up to two weeks~Cost $800-$1000 per monthly injection
![Page 25: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/25.jpg)
25
As cute as he may be….he is still there
![Page 26: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/26.jpg)
26
Benzodiazepine use in MAT
If an individual is benzodiazepine dependent, consider detoxification first and/or work with prescriber for consideration of alternative medications/ approaches.
![Page 27: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/27.jpg)
27
Challenges to MAT:
~Profit motives
~Harm Reduction vs. Drug Free models~Diversion issues~Individual not consistently taking medication~Individual not participating in therapy~Medical complications~Stigma- “drug replacement therapy”~LIFE-no treatment option is guaranteed!
![Page 28: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/28.jpg)
28
MAT should continue as long as the patient desires and derives benefit from treatment.
There should be no fixed length of time in treatment.
![Page 29: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/29.jpg)
29
…resolution with a final result.
Webster dictionary defines that as completion or in the world of addiction a CURE. We haven’t gotten there yet!
Therefore, an individual may need multiple attempts to get it right as different stressors (or even the same stressors as before treatment) may return.
![Page 30: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/30.jpg)
30
WITHOUT TREATMENT WE HAVE ZERO CHANCE AT RECOVERY & PREVENTION!!!
I BELIEVE IT IS SAFE TO SAY-WE HAVE WITNESSED THE ALTERNATIVE!
![Page 31: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/31.jpg)
31
PYRAMID HEALTHCARE, INC. offers MAT in the following locations:
Pyramid Pittsburgh Outpatient (Suboxone®/Methadone), Pyramid Pittsburgh Inpatient/Detox (Suboxone®/Methadone)Pyramid Southside Outpatient (Suboxone®/Vivitrol)Foundations Medical Services, LLC (Methadone/Suboxone®*)Pyramid Dolminis (Methadone)Altoona Outpatient (Suboxone®/Vivitrol®**)Duncansville Inpatient/Detox(Suboxone®/Vivitrol®/Methadone)Chambersburg Outpatient (Suboxone®)York Pharmacotherapy Services (Suboxone®/Methadone)Today Inc. Inpatient (Vivitrol®)*-Self pay only**-Must be started in inpatient first
![Page 32: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/32.jpg)
32
Coming Soon:Allentown Outpatient (Suboxone®/Vivitrol®)
Hillside (Vivitrol®)
Call 1-888-694-9996 FOR MORE INFORMATION & REFFERAL
![Page 33: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/33.jpg)
33
References:
Substance Abuse and Mental Health Services Administration (SAMHSA) website, about medication assisted treatment http://www.dpt.samsha./gov
SAMHSA Treatment Improvement Protocol #43 & #40
Community Care Behavioral Health decision tool algorithm on the use of medication assisted treatment
Alkermes prescribing information packet for Vivitrol®
Federal Guidelines for Opioid Treatment Programs
![Page 34: MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649dbb5503460f94aac8b8/html5/thumbnails/34.jpg)
34
THANK YOU
&
QUESTIONS